References

1.      Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. ROP in middle-income countries.Lancet. 1997; 350: 12-14.

2.      Hwang CK,Hubbard GB,Hutchison AK,Lambert SR.Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity:A 5 year retrospective analysis.Ophthalmology.2015 May;122(5)1008-15.

3.      H. Blencowe, J. E. Lawn, T. Vazquez, A. Fielder, C. Gilbert, Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010, Pediatric Research,2013, 74(1), 35–49.

4.      W. V. Good, R. J. Hardy, V. Dobson et al.Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial, Arch Ophthalmol. 2010 Jun 128(6):663-71.

5.      Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002; 120:1470–1476. 

6.      Jalali S, Anand R, Kumar H, Dogra MR, Azad R, Gopal L. Programme planning and screening strategy in retinopathy of prematurity. IndianJ Ophthalmol.2003; 51:89–99.

7.      Drenser KA, Trese MT, Capone A., Jr Aggressive posterior retinopathy of prematurity.Retina. 2010;30(4 Suppl):37–40. 

8.      International Committee for the Classif-ication of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol.2005;123:991–9.

9.      J. Hu, M. P. Blair, M. J. Shapiro, S. J. Lichtenstein, J. M. Galasso, R. Kapur, Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012; 130(8):1000-1006.

10.  Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity.Results  of early treatment of retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121:1684–94

11.  Cook A, White S, Batterbury M, Clark D, Ocular growth and refractive error development in premature infants with or without retinopathy of prematurity.Invest Ophthalmol Vis Sci. 2008;49:5199–5207.

12.  Deeksha Katoch, Gaurav Sanghi, Mangat R Dogra, Nikhil Beke, Amod Gupta-Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes-Indian J Ophthalmol. 2011 Nov-Dec; 59(6): 423–426.

13.  Gunn DJ, Cartwright DW, Gole GA. Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity.Clin Exp Ophthalmol. 2014 Jul;42(5) :459-65.

14.  Shah PK, Ramakrishnan M, Sadat B, Bachu S, Narendran V, Kalpana N. Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of premat-urity. Oman J Ophthalmol 2014; 7(3): 116–119.

15.  Murat Gunay, Gokhan Celik, BetulOnal Gunay,Alev Aktas, Guner Karatekin, Fahri Ovali Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity Arq. Bras. Oftalmol.2015; 78(5):300-4.

16.  Coats DK, Miller AM, Hussein MAW, et al. Involution of retinopathy of prematurity after laser treatment: Factors associated with development of retinal detach-ment. Am J Ophthalmol. 2005;140:214–22. 

17.  Sanghi G,Dogra MR,Katoch D,Gupta A.Aggressive posterior retinopathy of prematurity in infants  ≥1500 g birth wei-ght. Indian J Ophthalmol 2014;62:254-7

18.  Y J Ahn, K E Hong, H R Yum, J H Lee, K S Kim, Y A Youn et al. Characteristic clinical features associated with aggressive posterior retinopathy of prematurity. Eye, February 2017

19.  Sanghi G,Dogra MR,Katoch D,Gupta A.Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation.Am J Ophthalmol.2013 Jan;155(1):159-164.

20.  Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15. 

21.  Nicoara SD, Stefanuţ AC, Nascutzy C, Zaharie GC, Toader LE, Drugan TC. Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Anal-ysis.  Medical Science Monitor : Intern-ational Medical Journal of Experimental and Clinical Research. 2016;22:1192-1209.

22.  Yang CS, Wang AG, Sung CS, Hsu WM, Lee FL, Lee SM. Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: A study of refractive status at 7 years. Eye.  2010;24:14–20.

23.  Varughese S, Varghese RM, Gupta N, Ojha R, Sreenivas V, Puliyel JM. Refractive error at birth and its relation to gestational age. Curr Eye Res. 2005; 30:423–8.

Corresponding Author

Anuja Sathar

Assistant Professor, Regional Institute of Ophthalmology

Govt Medical College, Thiruvananthapuram, Kerala, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone Number: 9446582337, 9447072337, Fax Number: 91-471-2307749